High Tide Inc
NASDAQ:HITI

Watchlist Manager
High Tide Inc Logo
High Tide Inc
NASDAQ:HITI
Watchlist
Price: 2.66 USD -0.75% Market Closed
Market Cap: 214m USD

Relative Value

The Relative Value of one HITI stock under the Base Case scenario is 4.54 USD. Compared to the current market price of 2.66 USD, High Tide Inc is Undervalued by 41%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HITI Relative Value
Base Case
4.54 USD
Undervaluation 41%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
84
Median 3Y
0.4
Median 5Y
0.5
Industry
2.7
Forward
0.5
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-8.8
Industry
21.6
Forward
-57.3
vs History
36
vs Industry
41
Median 3Y
10.1
Median 5Y
9.7
Industry
16.9
vs History
42
vs Industry
1
Median 3Y
17.4
Median 5Y
8.5
Industry
22.9
vs History
31
vs Industry
43
Median 3Y
1.6
Median 5Y
1.8
Industry
2.3
vs History
47
vs Industry
85
Median 3Y
0.5
Median 5Y
0.5
Industry
3
Forward
0.5
vs History
44
vs Industry
72
Median 3Y
1.8
Median 5Y
2
Industry
5.6
vs History
55
vs Industry
39
Median 3Y
8
Median 5Y
9.8
Industry
13.4
Forward
8.1
vs History
28
vs Industry
21
Median 3Y
21.1
Median 5Y
-7.1
Industry
16.7
Forward
38.1
vs History
42
vs Industry
40
Median 3Y
10.2
Median 5Y
10.1
Industry
16.1
vs History
22
vs Industry
27
Median 3Y
12.7
Median 5Y
10.7
Industry
18.9
vs History
28
vs Industry
46
Median 3Y
1.2
Median 5Y
1.3
Industry
2

Multiples Across Competitors

HITI Competitors Multiples
High Tide Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
High Tide Inc
NASDAQ:HITI
302.8m USD 0.5 -30.9 8.3 22.9
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
491.8B USD 5.3 19.6 16 20.8
CH
Roche Holding AG
SIX:ROG
271.4B CHF 4.4 28.8 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
220.4B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
274.9B USD 4.3 14.4 10.2 12.1
CH
Novartis AG
SIX:NOVN
218.8B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.9B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
CA
High Tide Inc
NASDAQ:HITI
Average P/E: 24.9
Negative Multiple: -30.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
High Tide Inc
NASDAQ:HITI
Average EV/EBITDA: 400.7
8.3
30%
0.3
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
High Tide Inc
NASDAQ:HITI
Average EV/EBIT: 1 714.5
22.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5